Stocks to watch: RIL, ONGC, Swiggy, Paras Defence, Glenmark Pharma, IRCON, Senores Pharma in focus

/ 2 min read
Summary

Markets to open flat amid mixed global signals; Swiggy, Reliance, Paras Defence, Glenmark, and IRCON in spotlight

Paras Defence and Space Technologies shares rise 10% to  ₹1,293.30 on the BSE today
Paras Defence and Space Technologies shares rise 10% to ₹1,293.30 on the BSE today | Credits: Getty Images

The Indian benchmark indices BSE Sensex and NSE Nifty are set to start the day on a flat note, tracking mixed cues from global equity markets and muted trends in GIFT Nifty futures. At 7:20 AM, the GIFT Nifty index was up 11.5 points, or 0.05%, at 24,572, indicating a subdued opening for domestic equity benchmarks.

ADVERTISEMENT
Sign up for Fortune India's ad-free experience
Enjoy uninterrupted access to premium content and insights.

Here are the stocks that will be in focus in today's trade:

Swiggy: The foodtech company’s hyperlocal parcel delivery service Genie, which was launched in 2020, has stopped its operations temporarily, according to information shared by the company's customer care service on X.

Reliance Industries, ONGC: The Panna-Mukta and Tapti (PMT) joint venture partners - Shell (through BGEPIL), Reliance Industries Limited (RIL), and Oil and Natural Gas Corporation Limited (ONGC) have successfully completed the country’s first offshore facilities decommissioning project with the safe removal of mid and south Tapti field facilities.

Paras Defence and Space Technologies: The defence company has inked a pact with Israel-based HevenDrones to form a joint venture in India for the development and production of logistics and cargo drones for both defence and civil markets.

Senores Pharmaceuticals: The drug maker, through its wholly-owned subsidiary Senores Pharmaceuticals Inc., USA, has signed a deal to acquire the USFDA-approved Topiramate drug from Wockhardt. The drug is used for the treatment of epilepsy and migraine.

Glenmark Pharmaceuticals: The company, an alliance between Ichnos Sciences Inc., a global fully-integrated clinical-stage biotech company developing multispecifics in oncology, and its parent, Glenmark Pharmaceuticals, said that US Food and Drug Administration (FDA) has granted Fast Track designation for ISB 2001.

Recommended Stories

Indian Energy Exchange: The electricity exchange achieved a monthly electricity traded volume of 10,584 MU in April, up 26% year-on-year (YoY).

IRCON International: The PSU company has secured an order worth Rs 187.08 crore from Kerala State IT Infrastructure for the construction of a Dedicated Rural Industrial Park in Thiruvananthapuram.

ADVERTISEMENT

RateGain Travel Technologies: The company has appointed Deepak Kapoor as its new Chief Technology Officer (CTO) and Rohan Mittal as the new Chief Financial Officer (CFO).

Cyient: The company's U.S-based subsidiary Cyient Inc., has received an order levying a penalty of $26,779.74 towards Employer Shared Responsibility Payment (ESRP) from the US Department of the Treasury, Internal Revenue Service (IRS).

Fortune 500 India 2025A definitive ranking of India’s largest companies driving economic growth and industry leadership.
RANK
COMPANY NAME
REVENUE
(INR CR)
View Full List >
Explore the world of business like never before with the Fortune India app. From breaking news to in-depth features, experience it all in one place. Download Now